| Alpha-fetoprotein as a potential surrogate biomarker for atezolizumab+ bevacizumab treatment of hepatocellular carcinoma AX Zhu, F Dayyani, CJ Yen, Z Ren, Y Bai, Z Meng, H Pan, P Dillon, ... Clinical Cancer Research 28 (16), 3537-3545, 2022 | 78 | 2022 |
| COVID-19 in ocrelizumab-treated people with multiple sclerosis R Hughes, L Whitley, K Fitovski, HM Schneble, E Muros, A Sauter, ... Multiple sclerosis and related disorders 49, 102725, 2021 | 73 | 2021 |
| Group‐based trajectory models: assessing adherence to antihypertensive medication in older adults in a community pharmacy setting P Dillon, D Stewart, SM Smith, P Gallagher, G Cousins Clinical Pharmacology & Therapeutics 103 (6), 1052-1060, 2018 | 49 | 2018 |
| Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb) C Lawlor, MP O’Sullivan, B Rice, P Dillon, PJ Gallagher, S O’Leary, ... Journal of Materials Science: Materials in Medicine 23, 89-98, 2012 | 29 | 2012 |
| Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population P Dillon, SM Smith, P Gallagher, G Cousins BMC public health 18, 1-9, 2018 | 23 | 2018 |
| Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study P Dillon, KK O’Brien, R McDonnell, E Donnelly-Swift, R Galvin, A Roche, ... BMC Pregnancy and Childbirth 15, 1-9, 2015 | 21 | 2015 |
| The association between pharmacy refill-adherence metrics and healthcare utilisation: a prospective cohort study of older hypertensive adults P Dillon, SM Smith, P Gallagher, G Cousins International Journal of Pharmacy Practice 27 (5), 459-467, 2019 | 20 | 2019 |
| Association between gaps in antihypertensive medication adherence and injurious falls in older community-dwelling adults: a prospective cohort study P Dillon, SM Smith, PJ Gallagher, G Cousins BMJ open 9 (3), e022927, 2019 | 18 | 2019 |
| Assessing the multidimensional relationship between medication beliefs and adherence in older adults with hypertension using polynomial regression P Dillon, LA Phillips, P Gallagher, SM Smith, D Stewart, G Cousins Annals of behavioral medicine 52 (2), 146-156, 2018 | 16 | 2018 |
| Determinants of intentions to monitor antihypertensive medication adherence in Irish community pharmacy: a factorial survey P Dillon, R McDowell, SM Smith, P Gallagher, G Cousins BMC Family Practice 20, 1-14, 2019 | 9 | 2019 |
| Alpha-fetoprotein (AFP) kinetics as a potential surrogate biomarker in patients (pts) with hepatocellular carcinoma (HCC) treated with atezolizumab (atezo)+ bevacizumab (bev) AX Zhu, F Dayyani, CJ Yen, Z Ren, Y Bai, Z Meng, H Pan, P Dillon, ... ILCA Annual Conference-Book of Abstracts 12, 2020 | 7 | 2020 |
| Medication monitoring attitudes and perceived determinants to offering medication adherence advice to older hypertensive adults: a factorial survey of community pharmacy interns P Dillon, SM Smith, P Gallagher, G Cousins International Journal of Pharmacy Practice 27 (1), 45-54, 2019 | 5 | 2019 |
| A Theory of Planned Behavior informed factorial survey of New York community pharmacists to determine their intentions to monitor antihypertensive medication adherence among … E Unni, J Han, P Dillon Journal of the American Pharmacists Association 62 (5), 1572-1580, 2022 | 3 | 2022 |
| The socioeconomic impact of disability progression in multiple sclerosis: a retrospective cohort study of the German NeuroTransData (NTD) registry P Dillon, Y Heer, E Karamasioti, E Muros-Le Rouzic, G Marcelli, D Di Maio, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 9 (3 …, 2023 | 2 | 2023 |
| Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis P Dillon, A Siadimas, S Roumpanis, O Fajardo, K Fitovski, N Jessop, ... Multiple Sclerosis and Related Disorders 71, 104512, 2023 | 2 | 2023 |
| Validity of an electronic health record (EHR) and claims-derived proxy measure of multiple sclerosis (MS) disability P Dillon, S Roumpanis, EM Le Rouzic PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 443-444, 2022 | 1 | 2022 |
| Examining the relationship between wound complications and the use of resorbable plates in cranial vault reconstruction FOF Reilly, S Clinton, P Dillon, S Carr, S Bracken, J Caird, DJ Murray Journal of Craniofacial Surgery 32 (7), 2310-2313, 2021 | 1 | 2021 |
| A real-world data study of coronavirus-2019 disease severity in patients with multiple sclerosis treated with ocrelizumab P Dillon, A Waqar, S Roumpanis, M Martinec, ML Rouzic Multiple Sclerosis Journal, 103-104, 2020 | 1 | 2020 |
| Factorial survey methodology to inform pharmacy adherence interventions: comparison of two international studies P Dillon, E Unni, J Han Research in Social and Administrative Pharmacy 19 (7), 21, 2023 | | 2023 |
| EE167 The Socioeconomic Impact of Disability Progression in Multiple Sclerosis: A Retrospective Cohort Study of the German Neurotransdata (NTD) Registry G Kobelt, P Dillon, Y Heer, E Karamasioti, E Muros-Le Rouzic, G Marcelli, ... Value in Health 25 (12), S85, 2022 | | 2022 |
